Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

被引:266
|
作者
Ferslew, Brian C. [1 ,2 ]
Xie, Guoxiang [3 ]
Johnston, Curtis K. [1 ]
Su, Mingming [3 ]
Stewart, Paul W. [4 ]
Jia, Wei [3 ]
Brouwer, Kim L. R. [1 ]
Barritt, A. Sidney [5 ]
机构
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA
[2] Theravance Biopharma US Inc, Clin Pharmacol & Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[3] Univ Hawaii, Ctr Canc, Metabol Shared Resource, Honolulu, HI 96813 USA
[4] Univ N Carolina, UNC Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, UNC Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
Nonalcoholic steatohepatitis; Bile acids; Bile acid metabolome; Enterohepatic recirculation; FATTY LIVER-DISEASE; URSODEOXYCHOLIC ACID; ACTIVATION; APOPTOSIS; RECEPTOR; CANCER; INJURY; METAANALYSIS; HOMEOSTASIS; POPULATION;
D O I
10.1007/s10620-015-3776-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The prevalence of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the development and progression of NAFLD to NASH and cirrhosis is poorly understood. This study aimed to quantify the bile acid metabolome in healthy subjects and patients with non-cirrhotic NASH under fasting conditions and after a standardized meal. Liquid chromatography tandem mass spectroscopy was used to quantify 30 serum and 16 urinary bile acids from 15 healthy volunteers and 7 patients with biopsy-confirmed NASH. Bile acid concentrations were measured at two fasting and four post-prandial time points following a high-fat meal to induce gallbladder contraction and bile acid reabsorption from the intestine. Patients with NASH had significantly higher total serum bile acid concentrations than healthy subjects under fasting conditions (2.2- to 2.4-fold increase in NASH; NASH 2595-3549 A mu M and healthy 1171-1458 A mu M) and at all post-prandial time points (1.7- to 2.2-fold increase in NASH; NASH 4444-5898 A mu M and healthy 2634-2829 A mu M). These changes were driven by increased taurine- and glycine-conjugated primary and secondary bile acids. Patients with NASH exhibited greater variability in their fasting and post-prandial bile acid profile. Results indicate that patients with NASH have higher fasting and post-prandial exposure to bile acids, including the more hydrophobic and cytotoxic secondary species. Increased bile acid exposure may be involved in liver injury and the pathogenesis of NAFLD and NASH.
引用
收藏
页码:3318 / 3328
页数:11
相关论文
共 50 条
  • [1] Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
    Brian C. Ferslew
    Guoxiang Xie
    Curtis K. Johnston
    Mingming Su
    Paul W. Stewart
    Wei Jia
    Kim L. R. Brouwer
    A. Sidney Barritt
    [J]. Digestive Diseases and Sciences, 2015, 60 : 3318 - 3328
  • [2] Altered Morphine Glucuronide and Bile Acid Disposition in Patients With Nonalcoholic Steatohepatitis
    Ferslew, B. C.
    Johnston, C. K.
    Tsakalozou, E.
    Bridges, A. S.
    Paine, M. F.
    Jia, W.
    Stewart, P. W.
    Barritt, A. S.
    Brouwer, K. L. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (04) : 419 - 427
  • [3] Altered bile acid composition and disposition in a mouse model of nonalcoholic steatohepatitis
    Suga, Takahiro
    Yamaguchi, Hiroaki
    Ogura, Jiro
    Shoji, Saori
    Maekawa, Masamitsu
    Mano, Nariyasu
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 379
  • [4] Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
    Fiorucci, Stefano
    Biagioli, Michele
    Sepe, Valentina
    Zampella, Angela
    Distrutti, Eleonora
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 623 - 632
  • [5] Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets
    Cheng, Zilu
    Chen, Yixiong
    Schnabl, Bernd
    Chu, Huikuan
    Yang, Ling
    [J]. JOURNAL OF ADVANCED RESEARCH, 2024, 59 : 173 - 187
  • [6] Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
    Tanaka, Naoki
    Matsubara, Tsutomu
    Krausz, Kristopher W.
    Patterson, Andrew D.
    Gonzalez, Frank J.
    [J]. HEPATOLOGY, 2012, 56 (01) : 118 - 129
  • [7] EFFECTS OF INDIVIDUAL BILE ACID FEEDING ON NONALCOHOLIC STEATOHEPATITIS DEVELOPMENT IN LOW BILE ACID MOUSE MODEL
    Taylor, Rulaiha E.
    Meadows, Vik
    Capece, Gina
    Basaly, Veronia
    Henry, Zakiyah
    Otersen, Katherine D.
    Kong, Bo
    Guo, Grace L.
    [J]. HEPATOLOGY, 2023, 78 : S1087 - S1088
  • [8] Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis
    Lastuvkova, Hana
    Nova, Zuzana
    Hroch, Milos
    Faradonbeh, Fatemeh Alaei
    Schreiberova, Jolana
    Mokry, Jaroslav
    Faistova, Hana
    Stefela, Alzbeta
    Dusek, Jan
    Kucera, Otto
    Hyspler, Radomir
    Dohnalkova, Ester
    Bayer, Rachel L.
    Hirsova, Petra
    Pavek, Petr
    Micuda, Stanislav
    [J]. TOXICOLOGICAL SCIENCES, 2023, 196 (02) : 200 - 217
  • [9] Targeting hepatic ceruloplasmin mitigates nonalcoholic steatohepatitis by modulating bile acid metabolism
    Jiang, Quanxin
    Wang, Ning
    Lu, Sijia
    Xiong, Jie
    Yuan, Yanmei
    Liu, Junli
    Chen, Suzhen
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2024, 15 (09)
  • [10] Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
    Lu, Yifei
    Shao, Mingmei
    Zhang, Caiyun
    Xiang, Hongjiao
    Wang, Junmin
    Wu, Tao
    Ji, Guang
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13